Resultados de la búsqueda 291-300 of 14926 for Dr. Sunanda Kane

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   We hypothesize that targeting melanoma with a PD-1 (MC9324) CAR TIL therapy would capitalize on the tumor homing machinery of the TIL to drive ... Dr. Joseph ...

2. Radiología - Ensayos clínicos - Mayo Clinic

   Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to the early treatment of these complex injuries.

3. Cirugía - Ensayos clínicos - Mayo Clinic

   Rochester, Minn., Jacksonville, Fla. To collect post-approval data comparing the safety and effectiveness of CraniSeal Dural Sealant to DuraSeal Dural Sealant.

4. Radiología - Ensayos clínicos - Mayo Clinic

   Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to the early treatment of these complex injuries.

5. Cirugía - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   We hypothesize that targeting melanoma with a PD-1 (MC9324) CAR TIL therapy would capitalize on the tumor homing machinery of the TIL to drive ... Dr. Joseph ...

7. Radiología - Ensayos clínicos - Mayo Clinic

   Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to the early treatment of these complex injuries.

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

9. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and tissue samples) to improve the overall ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...